Fasoracetam
Fasoracetam (NS 105) is the activator of metabotropic glutamate receptor (mGluR) . Fasoracetam (NS 105) has the potential for the research of attention-deficit hyperactivity disorder (ADHD) and Alzheimer's disease (AD) [1][2].
Product Specifications
CAS Number
[110958-19-5]
Product Name Alternative
NS 105
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/fasoracetam.html
Purity
99.41
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1NC(CC1)=O)N2CCCCC2
Molecular Formula
C10H16N2O2
Molecular Weight
196.25
Precautions
H302, H315, H319, H335
References & Citations
[1]Elia J, et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. Nat Commun. 2018;9 (1) :4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
168686-AF-ML650 100 µL
CD31 (PECAM-1, EndoCAM, PECA1, Platelet Endothelial Cell Adhesion Molecule 1, GPIIA') (BSA & Azide Free) (MaxLight 650)
Sign In for Pricing
View Details 
035805-APC 200 µL
FUT8, ID (FUT8, Alpha- (1,6) -fucosyltransferase, Fucosyltransferase 8, GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase, GDP-fucose-glycoprotein fucosyltransferase, Glycoprotein 6-alpha-L-fucosyltransferase) (APC) discontinued
Sign In for Pricing
View Details